|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Melinta Therapeutics, Inc (MLNT) |
|
|
$0.11 0.00 (0.00%) as of 4:30 Tue 6/2
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
56,020,000 |
| Market
Cap: |
6.16(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.11 - $0.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Oldach David W. |
Chief Medical Officer |
• – – |
2015-12-15 |
4 |
AS |
$30.00 |
$53,340 |
D/D |
(1,778) |
1,100 |
|
- |
|
| Oldach David W. |
Chief Medical Officer |
• – – |
2015-12-15 |
4 |
OE |
$2.28 |
$4,054 |
D/D |
1,778 |
2,878 |
|
- |
|
| Oldach David W. |
Chief Medical Officer |
• – – |
2015-12-11 |
4 |
AS |
$30.33 |
$249,373 |
D/D |
(8,222) |
1,100 |
|
- |
|
| Oldach David W. |
Chief Medical Officer |
• – – |
2015-12-11 |
4 |
OE |
$2.28 |
$18,746 |
D/D |
8,222 |
9,322 |
|
- |
|
| Oldach David W. |
Chief Medical Officer |
• – – |
2015-11-09 |
4 |
S |
$28.78 |
$351,116 |
D/D |
(12,200) |
1,100 |
|
- |
|
| Oldach David W. |
Chief Medical Officer |
• – – |
2015-11-09 |
4 |
OE |
$2.28 |
$22,800 |
D/D |
10,000 |
13,300 |
|
- |
|
| Dougherty Michael R |
Director |
– • – |
2015-10-26 |
4 |
B |
$18.45 |
$36,896 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| Kong Garheng |
Director |
– • – |
2015-10-26 |
4 |
B |
$17.43 |
$49,335 |
D/D |
2,830 |
2,830 |
2.39 |
- |
|
| Dougherty Dennis |
10% Owner |
– – • |
2015-08-18 |
4 |
OE |
$6.00 |
$236,856 |
I/I |
39,476 |
963,502 |
|
- |
|
| Dougherty Dennis |
10% Owner |
– – • |
2015-08-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000,000) |
939,816 |
|
- |
|
| Kent Richard S |
Director |
– • – |
2015-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
392 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2015-06-22 |
4 |
AS |
$35.74 |
$1,787,000 |
D/D |
(50,000) |
50 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2015-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
50,050 |
|
- |
|
| Fernandes Prabhavathi |
President and CEO |
• • – |
2015-05-22 |
4 |
S |
$35.72 |
$321,489 |
D/D |
(9,000) |
247,678 |
|
- |
|
| Fernandes Prabhavathi |
President and CEO |
• • – |
2015-05-22 |
4 |
OE |
$2.09 |
$318,792 |
D/D |
37,389 |
256,678 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2015-05-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,099,950) |
2,193,110 |
|
- |
|
| Kent Richard S |
Director |
– • – |
2015-03-04 |
4 |
OE |
$13.10 |
$196,500 |
D/D |
15,000 |
15,392 |
|
- |
|
| Moore David |
Chief Commercial Officer |
• – – |
2015-03-04 |
4 |
A |
$32.59 |
$32,590 |
D/D |
1,000 |
1,000 |
|
- |
|
| Oldach David W. |
Chief Medical OfficerOfficer |
• – – |
2015-01-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,300 |
|
- |
|
| Johnson John H |
Director |
– • – |
2014-05-23 |
4 |
B |
$9.10 |
$90,980 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Fernandes Prabhavathi |
President and CEO |
• • – |
2014-05-14 |
4 |
OE |
$1.43 |
$17,310 |
D/D |
12,105 |
219,289 |
|
- |
|
| Neff Sherrill P |
Director |
– • – |
2013-06-19 |
4 |
B |
$7.00 |
$1,855,000 |
I/I |
265,000 |
3,527,154 |
2.1 |
- |
|
| Quaker Bioventures Capital Ii, L.p. |
10% Owner |
– – • |
2013-06-19 |
4 |
B |
$7.00 |
$1,855,000 |
D/D |
265,000 |
3,527,154 |
2.45 |
- |
|
| Fernandes Prabhavathi |
President and CEO |
• • – |
2013-05-09 |
4 |
B |
$8.60 |
$30,100 |
D/D |
3,500 |
207,184 |
2.81 |
- |
|
| Morris I Wistar Iii |
10% Owner |
– – • |
2012-08-17 |
4 |
OE |
$7.62 |
$19,050 |
D/D |
2,500 |
744,533 |
|
- |
|
65 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
